Research theme for competitive and other funds (3):
2022 - 2025 骨吸収抑制薬関連顎骨壊死に対する最適な高気圧酸素療法の確立
2014 - 2017 Application as the prognosis marker of DNp53 in oral squamous cell carcinoma
2012 - 2014 DN p53 mutants in OSCC are expected to be useful for diagnosis and therapeutic strategy fitting the individual patients.
Papers (27):
中村裕介, 中村裕介, 佐藤淳, 加藤泰史, 加藤泰史, 吉川和人, 佐藤明, 北川善政. A case of rhinocerebral mucormycosis detected via maxillary osteonecrosis. 日本口腔外科学会雑誌. 2023. 69. 7. 353-360
Hironobu Hata, Kenji Imamachi, Michihiro Ueda, Masashi Matsuzaka, Hiroaki Hiraga, Toshihisa Osanai, Toru Harabayashi, Katsuya Fujimoto, Satoshi Oizumi, Masato Takahashi, et al. Response to: Prognosis of metastatic bone cancer and myeloma patients and long-term risk of medication-related osteonecrosis of the jaw (MRONJ): some critical points. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2022. 30. 12. 9693-9695
Hironobu Hata, Kenji Imamachi, Michihiro Ueda, Masashi Matsuzaka, Hiroaki Hiraga, Toshihisa Osanai, Toru Harabayashi, Katsuya Fujimoto, Satoshi Oizumi, Masato Takahashi, et al. Prognosis by cancer type and incidence of zoledronic acid-related osteonecrosis of the jaw: a single-center retrospective study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2022. 30. 5. 4505-4514
Hironobu Hata, Yojiro Ota, Katsuhiko Uesaka, Yutaka Yamazaki, Tsubasa Murata, Chika Murai, Kazuhito Yoshikawa, Kenji Imamachi, Takashi Yurikusa, Yoshimasa Kitagawa. Oral adverse events due to zinc deficiency after pancreaticoduodenectomy requiring continuous intravenous zinc supplementation: a case report and literature review. BMC oral health. 2022. 22. 1. 52-52
Chika Murai, Ken-ichiro Sakata, Chisato Ouchi, Masanao Sonobe, Kazuhito Yoshikawa, Jun Sato, Akira Satoh, Aya Matsuda, Yoshimasa Kitagawa. Mandibular Carcinoma Cuniculatum around the Dental Implant in a Patient with Concurrent Management for Pemphigus Vulgaris: A Case Report. Oral. 2022. 2. 1. 49-61